BIOVF News and Press, Swedish Orphan Biovit Ord From 10/30/23

2023-10-30 12:17:25 ET More on Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB (publ) 2023 Q3 - Results - Earnings Call Presentation Apellis extends selloff as JPMorgan becomes latest to downgrade Historical earnings data for Swedish Orphan Biovitrum AB ...

CenterPoint Energy Inc (Holding Co) (CNP) is expected to report $0.37 for Q3 2023 The Hershey Company (HSY) is expected to report $2.47 for Q3 2023 ASE Technology Holding Co. Ltd. American Depositary Shares (each representing Two) (ASX) is expected to report for Q3 2023 Reliance Steel...

Swedish Orphan Biovitrum AB (BIOVF) is expected to report $0.09 for Q3 2023

2023-08-03 10:40:25 ET More on Apellis Pharmaceuticals Apellis: Exercise Caution In Response To Safety Signal (Rating Downgrade) Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space Apellis off 18% despite reassurance of safety of vision drug, earnin...

2023-07-18 16:45:19 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2023 Results Conference Call July 18, 2023 07:00 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Armin Reininger - Senior Scientific...

2023-07-18 08:24:42 ET Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q2 Non-GAAP EPS of SEK1.48. Revenue of SEK4.87B (+25.8% Y/Y) misses by $419.36M . For further details see: Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK1.48, revenue of SEK4.87M m...

2023-05-10 10:51:53 ET Shares of CTI BioPharma (NASDAQ: CTIC) were up more than 80% early Wednesday after the company announced it was getting bought out for $1.7 billion by Swedish Orphan Biovitrum AB (OTC: BIOVF) , also known as SOBI. CTI BioPharma specializes in targe...

2023-04-29 10:58:09 ET Swedish Orphan Biovitrum AB (publ) (BIOVF) Q1 2023 Earnings Conference Call April 27, 2023 8:00 a.m. ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Financial Officer Tony Hoos - Head of RDMA, Chief ...

2023-04-29 10:34:32 ET The following slide deck was published by Swedish Orphan Biovitrum AB (publ) in conjunction with their 2023 Q1 earnings call. For further details see: Swedish Orphan Biovitrum AB (publ) 2023 Q1 - Results - Earnings Call Presentation

2023-04-27 12:54:50 ET Swedish Orphan Biovitrum AB press release ( OTCPK:BIOVF ): Q1 Non-GAAP EPS of SEK3.60. Revenue of SEK5.24M. For further details see: Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.60, revenue of SEK5.24M